The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Dexamethasone Phosphate 4 mg/ml Solution for Injection



Pfizer Healthcare IrelandPA0822/201/001

Main Information

Trade NameDexamethasone Phosphate 4 mg/ml Solution for Injection
Active SubstancesDexamethasone sodium phosphate
Dosage FormSolution for injection
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/201/001

Group Information

ATC CodeH02AB Glucocorticoids
H02AB02 dexamethasone

Status

License statusAuthorised
Licence Issued28/07/1986
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusNot applicable
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back